
Final Decision Analytic Protocol (DAP)
... This document is intended to provide a decision analytical protocol that will be used to guide the assessment the safety, effectiveness and cost-effectiveness of tropism testing in HIV-1 as a marker for treatment with maraviroc and thus MSAC’s decision-making regarding its public funding. It was fin ...
... This document is intended to provide a decision analytical protocol that will be used to guide the assessment the safety, effectiveness and cost-effectiveness of tropism testing in HIV-1 as a marker for treatment with maraviroc and thus MSAC’s decision-making regarding its public funding. It was fin ...
English - International Union Against Tuberculosis and Lung Disease
... are in the world’s 10 highest-burden countries for tuberculosis, reaching millions of people in remote and underserved communities. In China alone, FIDELIS projects cover nearly half a billion people and have helped train tens of thousands of Chinese health workers. ‘The philosophy behind FIDELIS is ...
... are in the world’s 10 highest-burden countries for tuberculosis, reaching millions of people in remote and underserved communities. In China alone, FIDELIS projects cover nearly half a billion people and have helped train tens of thousands of Chinese health workers. ‘The philosophy behind FIDELIS is ...
depo-testosterone
... wrist and hand on a regular basis. Geriatrics (> 65 years of age): There are very limited controlled clinical study data supporting the use of testosterone in the geriatric population and virtually no controlled clinical studies on subjects aged 75 years and over. Geriatric patients treated with and ...
... wrist and hand on a regular basis. Geriatrics (> 65 years of age): There are very limited controlled clinical study data supporting the use of testosterone in the geriatric population and virtually no controlled clinical studies on subjects aged 75 years and over. Geriatric patients treated with and ...
Winter 2012 - Ontario College of Pharmacists
... electronic format of Pharmacy Connection, we heard from many members on their preference. There is still a large number of you who prefer print, but there are certainly significant numbers who would now, or at some time in the near future, be satisfied with an online-only version of the publication. ...
... electronic format of Pharmacy Connection, we heard from many members on their preference. There is still a large number of you who prefer print, but there are certainly significant numbers who would now, or at some time in the near future, be satisfied with an online-only version of the publication. ...
Opioids - Choose your language | Know Pain Educational Program
... of nsNSAIDs/coxibs in acute pain (i.e., for 7–10 days)? Risk of Death/Myocardial Infarction within First 7 Days of nsNSAID/Coxib Treatment in Patients with Previous Death/Myocardial Infarction ...
... of nsNSAIDs/coxibs in acute pain (i.e., for 7–10 days)? Risk of Death/Myocardial Infarction within First 7 Days of nsNSAID/Coxib Treatment in Patients with Previous Death/Myocardial Infarction ...
CHAPTER 2
... drug regimen reviews by a pharmacist. Unfortunately, this mandate does not define what the pharmacist should evaluate during this review. 1980 GAO Report critiques D.R.R. results The Government Accounting Office (GAO) evaluates the effectiveness of drug regimen reviews ( implemented in 1974) and sta ...
... drug regimen reviews by a pharmacist. Unfortunately, this mandate does not define what the pharmacist should evaluate during this review. 1980 GAO Report critiques D.R.R. results The Government Accounting Office (GAO) evaluates the effectiveness of drug regimen reviews ( implemented in 1974) and sta ...
Prior Authorization Drug Name Covered Uses Exclusion Criteria
... FOR MODERATE TO SEVERE CROHN'S DISEASE: TRIAL/FAILURE OF ONE OR MORE CONVENTIONAL THERAPIES FOR CROHN'S DISEASE SUCH AS CORTICOSTEROIDS, AZATHIOPRINE, MERCAPTOPURINE, METHOTREXATE, OR MESALAMINE. FOR ...
... FOR MODERATE TO SEVERE CROHN'S DISEASE: TRIAL/FAILURE OF ONE OR MORE CONVENTIONAL THERAPIES FOR CROHN'S DISEASE SUCH AS CORTICOSTEROIDS, AZATHIOPRINE, MERCAPTOPURINE, METHOTREXATE, OR MESALAMINE. FOR ...
POLICY FOR THE MANAGEMENT OF EXTRAVASATION CHEMOTHERAPY NETWORK GROUP
... this can reduce damage to tissues. However, extravasation may only become apparent 1-4 weeks after the administration (Ener 2004). No matter what the nature of the drug, if extravasation is suspected the initial action remains the same. The most important thing initially is to limit the amount of dr ...
... this can reduce damage to tissues. However, extravasation may only become apparent 1-4 weeks after the administration (Ener 2004). No matter what the nature of the drug, if extravasation is suspected the initial action remains the same. The most important thing initially is to limit the amount of dr ...
Discussion paper
... Global context and international obligations Canada is party to the three major United Nations (UN) Conventions on narcotic drugs. In the context of the Convention, Canada is obliged to criminalize the production, sale and possession of cannabis for non-medical and non-scientific purposes. Legaliza ...
... Global context and international obligations Canada is party to the three major United Nations (UN) Conventions on narcotic drugs. In the context of the Convention, Canada is obliged to criminalize the production, sale and possession of cannabis for non-medical and non-scientific purposes. Legaliza ...
Queensland Alcohol and Drug Withdrawal Clinical Practice Guidelines
... psychiatric units, correctional settings and community health services in the Queensland public health system (including non-government agencies funded by Queensland Health) are recommended to adopt these guidelines. These clinical practice guidelines update and supersede the Clinical Protocols for ...
... psychiatric units, correctional settings and community health services in the Queensland public health system (including non-government agencies funded by Queensland Health) are recommended to adopt these guidelines. These clinical practice guidelines update and supersede the Clinical Protocols for ...
A review of the differences and similarities between generic
... products containing a new active substance which was not authorised in the Community before 20 May 2004 (date of entry into force of Regulation (EC) No 726/ 2004) and which are intended for the treatment of AIDS, cancer, neurodegenerative disorder or diabetes. The centralised procedure is also manda ...
... products containing a new active substance which was not authorised in the Community before 20 May 2004 (date of entry into force of Regulation (EC) No 726/ 2004) and which are intended for the treatment of AIDS, cancer, neurodegenerative disorder or diabetes. The centralised procedure is also manda ...
SUBUTEX tablets
... death. Many, but not all post‐marketing reports regarding coma and death associated with the concomitant use of buprenorphine and benzodiazepines involved misuse by self‐injection. Deaths have also been reported in association with concomitant administration of buprenorphine with other depressa ...
... death. Many, but not all post‐marketing reports regarding coma and death associated with the concomitant use of buprenorphine and benzodiazepines involved misuse by self‐injection. Deaths have also been reported in association with concomitant administration of buprenorphine with other depressa ...
The Impact of Marijuana Policies on Youth: Clinical
... This technical report updates the 2004 American Academy of Pediatrics technical report on the legalization of marijuana. Current epidemiology of marijuana use is presented, as are definitions and biology of marijuana compounds, side effects of marijuana use, and effects of use on adolescent brain dev ...
... This technical report updates the 2004 American Academy of Pediatrics technical report on the legalization of marijuana. Current epidemiology of marijuana use is presented, as are definitions and biology of marijuana compounds, side effects of marijuana use, and effects of use on adolescent brain dev ...
Implementation of Tuberculosis Activities at HIV Service Delivery Sites
... How were the templates developed and reviewed? The draft TB-HIV SOPs were prepared by a team of EGPAF, JSI and JHU technical staff in the US. The final version was prepared following additional review of the draft for completeness and technical accuracy by staff in the US and country offices in Afri ...
... How were the templates developed and reviewed? The draft TB-HIV SOPs were prepared by a team of EGPAF, JSI and JHU technical staff in the US. The final version was prepared following additional review of the draft for completeness and technical accuracy by staff in the US and country offices in Afri ...
Compulsory Treatment for Substance Dependence: A Review of the
... committed, there is no requirement that either be issued by a specialist alcohol and drug practitioner following a personal assessment; ·· the committal process begins with an application to the District Court; families find it difficult to make applications; and there can be delays and problems sat ...
... committed, there is no requirement that either be issued by a specialist alcohol and drug practitioner following a personal assessment; ·· the committal process begins with an application to the District Court; families find it difficult to make applications; and there can be delays and problems sat ...
Helping Patients Who Drink Too Much: A Clinician`s Guide
... This version provides important updates and refinements to the Guide published in 2003: Broader audience: Whereas the previous Guide was targeted to primary care practitioners only, this edition is written for both primary care and mental health clinicians. Mental health patients are more likely th ...
... This version provides important updates and refinements to the Guide published in 2003: Broader audience: Whereas the previous Guide was targeted to primary care practitioners only, this edition is written for both primary care and mental health clinicians. Mental health patients are more likely th ...
Slides [PowerPoint]
... • Unintentional drug overdose is second leading cause of death in US with 40% due to Rx opioids (NEJM. 2010, Nov 18; 363: 1981) • Among patients receiving opioid prescriptions for pain, higher doses were associated with increased risk for over overdose death (JAMA. ...
... • Unintentional drug overdose is second leading cause of death in US with 40% due to Rx opioids (NEJM. 2010, Nov 18; 363: 1981) • Among patients receiving opioid prescriptions for pain, higher doses were associated with increased risk for over overdose death (JAMA. ...
Guidelines for the Accreditation of Opioid Treatment Programs Revised July 20, 2007
... addiction. To become certified, an OTP must meet the Federal opioid treatment standards in section 8.12 of the regulation, must have current valid accreditation status from a SAMHSA-approved accreditation body, and must comply with any other conditions for certification established by SAMHSA. Under ...
... addiction. To become certified, an OTP must meet the Federal opioid treatment standards in section 8.12 of the regulation, must have current valid accreditation status from a SAMHSA-approved accreditation body, and must comply with any other conditions for certification established by SAMHSA. Under ...
A Guide to Drug Therapy in Patients with Enteral
... The key to managing medications in enterally fed patients is to focus on prioritizing therapeutic goals. First, temporarily discontinue medications that are not immediately necessary (eg, hormone replacement therapy).9 Second, consider giving medications by an alternate route, such as transdermal, r ...
... The key to managing medications in enterally fed patients is to focus on prioritizing therapeutic goals. First, temporarily discontinue medications that are not immediately necessary (eg, hormone replacement therapy).9 Second, consider giving medications by an alternate route, such as transdermal, r ...
Foundations in Pharmacokinetics
... With an understanding of pharmacokinetics, pharmacists, doctors and other health-care professionals can increase the effectiveness, decrease the toxicity, or increase patient compliance with a therapeutic regimen. The majority of the adverse drug reactions seen in the clinic are dose-related, thus a ...
... With an understanding of pharmacokinetics, pharmacists, doctors and other health-care professionals can increase the effectiveness, decrease the toxicity, or increase patient compliance with a therapeutic regimen. The majority of the adverse drug reactions seen in the clinic are dose-related, thus a ...
al-yarmouk university college department of pharmacy curriculum
... care, including clinical services, reviewing medications for safety and efficacy, and providing drug information. Pharmacists, therefore, are the experts on drug therapy and are the primary health professionals who optimize medication use to provide patients with positive health outcomes. At present ...
... care, including clinical services, reviewing medications for safety and efficacy, and providing drug information. Pharmacists, therefore, are the experts on drug therapy and are the primary health professionals who optimize medication use to provide patients with positive health outcomes. At present ...
Clinical Guidelines for the Use of Buprenorphine in the Treatment of
... A large and diverse group of experts reviews the draft document closely. The Buprenorphine Expert Panel, a distinguished group of substance abuse experts and professionals in such related fields as primary care, mental health, and social services, worked with the Consensus Panel Chair and the CSAT D ...
... A large and diverse group of experts reviews the draft document closely. The Buprenorphine Expert Panel, a distinguished group of substance abuse experts and professionals in such related fields as primary care, mental health, and social services, worked with the Consensus Panel Chair and the CSAT D ...
Antiepileptic Drugs
... plasma level over a dosage interval is likely to be within the experimental error in an individual drug concentration measurement. Therefore, unless the dosage is changed or other drug therapy added, the time of measurement of antiepileptic drug levels does not present too much of a problem. From a ...
... plasma level over a dosage interval is likely to be within the experimental error in an individual drug concentration measurement. Therefore, unless the dosage is changed or other drug therapy added, the time of measurement of antiepileptic drug levels does not present too much of a problem. From a ...
Harm reduction

Harm reduction (or harm minimization) is a range of public health policies designed to reduce the harmful consequences associated with various human behaviors, both legal and illegal. Harm reduction policies are used to manage behaviors such as recreational drug use and sexual activity in numerous settings that range from services through to geographical regions. Critics of harm reduction typically believe that tolerating risky or illegal behaviour sends a message to the community that such behaviours are acceptable and that some of the actions proposed by proponents of harm reduction do not reduce harm over the long term.Needle-exchange programmes reduce the likelihood of users of heroin and other drugs sharing the syringes and using them more than once. Syringe-sharing can lead to infections such as HIV or hepatitis C can spread from user to users through the reuse of syringes contaminated with infected blood. Needle and syringe programme (NSP) and Opioid Substitution Therapy (OST) outlets in some settings offer basic primary health care. Safe injection site are legally sanctioned, medically supervised facilities designed to address public nuisance associated with drug use and provide a hygienic and stress-free environment for drug consumers. The facilities provide sterile injection equipment, information about drugs and basic health care, treatment referrals, and access to medical staff.Opioid replacement therapy (ORT), or opioid substitution therapy (OST), is the medical procedure of replacing an illegal opioid, such as heroin, with a longer acting but less euphoric opioid; methadone or buprenorphine are typically used and the drug is taken under medical supervision. Another approach is Heroin assisted treatment, in which medical prescriptions for pharmaceutical heroin (diacetylmorphine) are provided to heroin-dependent people. Toronto's Seaton House became the first homeless shelter in Canada to operate a ""wet shelter"" on a ""managed alcohol"" principle in which clients are served a glass of wine once an hour unless staff determine that they are too inebriated to continue. Previously, homeless alcoholics opted to stay on the streets often seeking alcohol from unsafe sources such as mouthwash, rubbing alcohol or industrial products which, in turn, resulted in frequent use of emergency medical facilities.A high amount of media coverage exists informing users of the dangers of driving drunk. Most alcohol users are now aware of these dangers and safe ride techniques like 'designated drivers' and free taxicab programmes are reducing the number of drunk-driving accidents. Many schools now provide safer sex education to teen and pre-teen students, who may engage in sexual activity. Since some adolescents are going to have sex, a harm-reductionist approach supports a sexual education which emphasizes the use of protective devices like condoms and dental dams to protect against unwanted pregnancy and the transmission of STIs. Since 1999 some countries have legalized prostitution, such as Germany (2002) and New Zealand (2003).Many street-level harm-reduction strategies have succeeded in reducing HIV transmission in injecting drug users and sex-workers. HIV education, HIV testing, condom use, and safer-sex negotiation greatly decreases the risk to the disease.